期刊文献+

艾迪注射液治疗中晚期妇科肿瘤32例疗效观察 被引量:2

Treatment of Gynecological Tumor in Intermediate and Late Stages by Aidie Injeotion:A Clinical Observation of 32 Cases
下载PDF
导出
摘要 目的:观察艾迪注射液治疗中晚期妇科肿瘤的临床疗效方法:将62例中晚期妇科肿瘤患者随机分为2组。治疗组32例,在对症支持治疗的基础上用艾迪注射液治疗。对照组30例,单纯对症支持治疗。观察比较2组临床疗效。结果:艾迪注射液具有较好的稳定瘤体的作用,还能够改善患者主要临床症状,尤其在腹痛、腹胀、乏力方面,与对照组比较,差异有显著性或非常显著性意义(P<0.05,P<0.01);艾迪注射液还有提高患者生存质量及增加患者体重等作用,与对照组比较,差异有显著性意义(P<0.05)。结论:艾迪注射液治疗中晚期妇科肿瘤对改善患者主要临床症状、提高生存质量、增加体重等方面具有良好的疗效。 Objective:To observe the clinical effect of Aidie injection(AI,爱迪注射液)for intermediate and late stages of gynecological tumor(ILGT).Methods:62 cases of ILGT were allocated to 2 groups randomly.The treatment group(32 cases)was treated by supporting treatment and added with AI,the control group by supporting treatment alone. After one course of treatment,the clinical effect was statistically observed.Results:AI can satisfactorily stabilize the tumor body,improve the chief symptoms,especially abdominal pain,flatulence and fatigue,showing markedly or very markedly significant difference as compared with control group(P<0.05,P<0.01);AI can also increase the life quality and body weight than that of control group(P<0.05).Conclusion:AI possesses good cu- rative effect for improving chief clinical symptoms.increasing life quality and body weight.
出处 《新中医》 CAS 北大核心 2007年第3期95-96,共2页 New Chinese Medicine
  • 相关文献

参考文献5

二级参考文献23

  • 1张平,章崇杰,刘杰,魏大鹏,赵宗容.改良MTT法检测自然杀伤细胞的活性[J].华西医科大学学报,1996,27(2):213-215. 被引量:32
  • 2[2]Holroyd EM,Twinn SB,Adab P.Socio-cultural influences on Chinese women's attendance for cervical screening.Journal of Advanced Nursing,2004,46 (1):42
  • 3[3]Gaffikin L,Lauterbach M,Blumenthal PD,et al.Performance of visual inspection with acetic acid for cervical cancer screening:A qualitative summary of evidence to date.Obstet & Gynecol Surv,2003,58 (8):543
  • 4[4]Duffymj,Bonfrer JM,Kulpa JS,et al.CA125 in ovarian cancer:European Group on Tumor Markers Guidelines for Clinical Use.In J Gynecol Cancer,2005,15 (5):679
  • 5[5]Menon U,Jacobs IJ.Ovarian cancer screening in the general population.Current Opinion in Obstet Gynecol,2001,13 (1):61
  • 6[6]Cannistra SA.Medical progress:Cancer of the ovary.N Engl J Med,2004,351 (24):2519
  • 7[7]Khoury-Collado F,Bombard AT.Hereditary breast and ovarian cancer:What the primary care physician should know.Obstet Gynecol Surv,2004,59 (7):537
  • 8[8]Clement PB,Young RH.Non-endometrioid carcinomas of the uterine corpus:A review of their pathology with emphasis on recent advances and problematic aspects.Adv Anat Pathol,2004,11 (3):117
  • 9[9]Ledger WJ.Human papillomavirus infection in women:An update.Infectious Diseases in Clinical Practice,2005,13 (4):154
  • 10[10]Van BM,de Craen AJ,de Vet HC,et al.The contribution of MIB 1 in the accurate grading of vulvar intraepithelial neoplasia.J Clin Pathol,1999,52:820

共引文献197

同被引文献36

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部